AU5437190A - Soluble cd4 produced in (e. coli) - Google Patents

Soluble cd4 produced in (e. coli)

Info

Publication number
AU5437190A
AU5437190A AU54371/90A AU5437190A AU5437190A AU 5437190 A AU5437190 A AU 5437190A AU 54371/90 A AU54371/90 A AU 54371/90A AU 5437190 A AU5437190 A AU 5437190A AU 5437190 A AU5437190 A AU 5437190A
Authority
AU
Australia
Prior art keywords
coli
soluble
produced
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU54371/90A
Inventor
Robert L. Garlick
Richard J. Kirschner
W. Gary Tarpley
Che-Shen C. Tomich
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia and Upjohn Co
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of AU5437190A publication Critical patent/AU5437190A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70514—CD4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AU54371/90A 1989-04-05 1990-03-20 Soluble cd4 produced in (e. coli) Abandoned AU5437190A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US333516 1981-12-22
US33351689A 1989-04-05 1989-04-05

Publications (1)

Publication Number Publication Date
AU5437190A true AU5437190A (en) 1990-11-05

Family

ID=23303119

Family Applications (1)

Application Number Title Priority Date Filing Date
AU54371/90A Abandoned AU5437190A (en) 1989-04-05 1990-03-20 Soluble cd4 produced in (e. coli)

Country Status (2)

Country Link
AU (1) AU5437190A (en)
WO (1) WO1990012031A1 (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0280710B1 (en) * 1986-08-21 1996-03-20 The Trustees Of Columbia University In The City Of New York Dna encoding the t cell surface protein t4 and use of fragments of t4 in the treatment of aids
KR890701605A (en) * 1987-07-04 1989-12-21 원본미기재 DNA sequence, recombinant DNA molecule and method for producing soluble T4 protein
AU3006789A (en) * 1988-02-24 1989-08-24 Smithkline Beckman Corporation Expression of hiv binding proteins

Also Published As

Publication number Publication date
WO1990012031A1 (en) 1990-10-18

Similar Documents

Publication Publication Date Title
DE69012817D1 (en) Poly(perfluorether)acyl-peroxide.
EP0580862A4 (en) Rapidly soluble solid preparation.
AU9075591A (en) N-halochitosans, their preparation and uses
AU8093487A (en) Improvement in bromphenriamine, pseudoephedrine therapy
AU7738287A (en) 1-substituted aryl-3-tert. butyl-pyrazoles
OA09196A (en) "Tétrahydroimidazo (1,4) benzodiazépin-2-thiones antivirales".
AU590915B2 (en) N-pyridyloxyphenylisothioureas,their production and use as pesticides.
AU6209790A (en) Pyridinyl-quinolone compounds, their preparation and use
HK1003005A1 (en) 2,4-Dimethyl-6-s-alkyl-phenols 2 ' 4.
AU4511489A (en) 14alpha,17alpha-ethano-estratrienes
AU628227B2 (en) Benzoxazinyl-pyrazoles, and their production and use
AU1959488A (en) (n-alpha-acyl, 8-glycine, des-19-leucine)-calcitonin
AU1004588A (en) Solution ibuprofen complexes, compositions and processes for preparing same
AU635954B2 (en) Edger
AU7214887A (en) Water-soluble saccharide polymers
OA09308A (en) Anti-HIV agent.
AU5388090A (en) N-sulfenyl- and n-sulfinyl-n,n'-diacylhydrazides
AU5437190A (en) Soluble cd4 produced in (e. coli)
AU5638190A (en) Transmission system, in particular ball link transmission system
AU629720B2 (en) Sulfonated propylphenylphosphines, their preparation and use
AU5827590A (en) Htlv-1 env gene products expressed in (e. coli)
AU643701B2 (en) 1-ethylphenoxathiin 10,10-dioxide
GB2219630B (en) Variable ratio coupling.
AU6157190A (en) Substituted n-heterocycles, their preparation and their use
AU1517888A (en) Des-19-leucine, 20-glutamine, 21-threonine, 22-tyrosine-calcitonin